liposomal contortrostatin (Molecular Express)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameliposomal contortrostatin (Molecular Express)

Drug Alias Namecontortrostatinliposomal contortrostatin

ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionIntegrin alpha-V/beta-3 antagonistsIntegrin alpha-IIb/beta-3 antagonistsIntegrin alpha-5/beta-1 inhibitors

TargetsIntegrin alpha-IIb/beta-3Integrin alpha-V/beta-3Integrin alpha-5/beta-1

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

ATC CodeN/A